Skip to content

Study · Animal study (in vivo) · rat · 2002

3 results

Possible mechanism underlying the effect of Semax on the formation of indomethacin-induced ulcers in rats.

Zhuikova SE, Sergeev VI, Samonina GE, Myasoedov NF

Bulletin of experimental biology and medicine1 Jun 2002Cited by 5 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with indomethacin-induced ulcers, intraperitoneal Semax produced a protective effect.

    In plain wordsIn rats with ulcers caused by indomethacin, Semax injected into the abdomen had a protective effect.

    Peptide
    Semax
    Outcome
    DecreaseIndomethacin-induced gastric ulcers
    Study

    ratn: not reported in source

    Indomethacin-induced ulcers
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    50 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Intraperitoneal injection of Semax (synthetic analogue of ACTH4-7, MEHFPGP) in a dose of 50 mg/kg produced a protective effect on rats with experimental indomethacin-induced ulcers.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In narcotized rats, Semax had no effect on basal blood flow in the stomach.

    In plain wordsIn anaesthetized rats, Semax did not change normal blood flow in the stomach.

    Peptide
    Semax
    Outcome
    No significant changeBasal gastric blood flow
    Study

    ratn: not reported in source

    Narcotized rats
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    50 mg/kgAs given in this study (rat).

    Source sentences

    Summary
    Experiments on narcotized rats showed that Semax in the studied dose had no effect on basal blood flow in the stomach, but prevented reduction of blood flow induced by indomethacin.
    1 context sentence
    Summary · context
    Intraperitoneal injection of Semax (synthetic analogue of ACTH4-7, MEHFPGP) in a dose of 50 mg/kg produced a protective effect on rats with experimental indomethacin-induced ulcers.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In narcotized rats, Semax prevented the reduction of stomach blood flow induced by indomethacin.

    In plain wordsIn anaesthetized rats, Semax prevented the drop in stomach blood flow caused by indomethacin.

    Peptide
    Semax
    Outcome
    IncreaseIndomethacin-induced reduction of gastric blood flow
    Study

    ratn: not reported in source

    Narcotized rats
    Outcome group
    Gastrointestinal protection · Gastrointestinal
    Studied dose
    50 mg/kgAs given in this study (rat).

    Source sentences

    Summary
    Experiments on narcotized rats showed that Semax in the studied dose had no effect on basal blood flow in the stomach, but prevented reduction of blood flow induced by indomethacin.
    1 context sentence
    Summary · context
    Intraperitoneal injection of Semax (synthetic analogue of ACTH4-7, MEHFPGP) in a dose of 50 mg/kg produced a protective effect on rats with experimental indomethacin-induced ulcers.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 19:08 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.